These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2524792)

  • 1. [Treatment of cancer of the prostate. Role of gonadorelin analogs].
    Steg A
    Presse Med; 1989 May; 18(20):1007-9. PubMed ID: 2524792
    [No Abstract]   [Full Text] [Related]  

  • 2. [LHRH analogs--new possibilities in the treatment of prostatic cancer].
    Baranowska B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):1009-12. PubMed ID: 6239145
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of carcinoma of the prostate with analogs of LHRH].
    Rubio Herrera MA; Calle Fernández JR
    Rev Clin Esp; 1986 Nov; 179(8):407-11. PubMed ID: 2951782
    [No Abstract]   [Full Text] [Related]  

  • 4. [Zoladex in prostatic carcinoma].
    Di Silverio F; Serio M
    Drugs Exp Clin Res; 1990; 16 Suppl():19-29. PubMed ID: 2150501
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of long-acting LHRH analog (Zoladex) on prostate cancer: evaluated by transrectal ultrasonography.
    Drago JR; Nesbitt JA; Cirulli C
    Urology; 1988 Oct; 32(4):285-7. PubMed ID: 2972104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatment for prostatic cancer.
    Lancet; 1983 Aug; 2(8347):438. PubMed ID: 6135918
    [No Abstract]   [Full Text] [Related]  

  • 7. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
    Chrisp P; Goa KL
    Drugs; 1991 Feb; 41(2):254-88. PubMed ID: 1709853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
    Eisenberger MA; O'Dwyer PJ; Friedman MA
    J Clin Oncol; 1986 Mar; 4(3):414-24. PubMed ID: 2936872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Luteinizing hormone-releasing hormone agonists for treatment of breast cancer].
    Gez E; Kovner F
    Harefuah; 1990 Jun; 118(11):655-8. PubMed ID: 2143745
    [No Abstract]   [Full Text] [Related]  

  • 10. Luteinising hormone-releasing hormone analogues alone in the treatment of advanced disease.
    Debruyne F
    Horm Res; 1989; 32 Suppl 1():62-4; discussion 64-5. PubMed ID: 2533157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gn-RH analogs and benign prostatic hypertrophy].
    Forti G; Serio M
    Drugs Exp Clin Res; 1990; 16 Suppl():31-2. PubMed ID: 1706977
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone therapy of male genital cancer (prostatic cancer)].
    Machida T; Ikemoto I
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2845-52. PubMed ID: 2444164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with different GnRH analogues in women: preliminary evidence for disparant effects on serum androgen concentrations.
    Rossmanith WG; Wirth U; Sasse V; Lauritzen C
    Horm Metab Res; 1991 Apr; 23(4):198-9. PubMed ID: 1831437
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine factors in the treatment of prostatic cancer.
    Pierrepoint CG; Turkes AO; Walker KJ; Harper ME; Wilson DW; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1985; 185A():51-72. PubMed ID: 3162177
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
    Debruyne FM; Karthaus HF; Schröder FH; de Voogt HJ; de Jong FH; Klijn JG
    Prog Clin Biol Res; 1985; 185A():251-70. PubMed ID: 3929265
    [No Abstract]   [Full Text] [Related]  

  • 16. Goserelin--another LH-RH analog for prostate cancer.
    Med Lett Drugs Ther; 1990 Nov; 32(830):102. PubMed ID: 1700261
    [No Abstract]   [Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone analogs and prostatic cancer.
    Swanson LJ; Seely JH; Garnick MB
    Crit Rev Oncol Hematol; 1988; 8(1):1-26. PubMed ID: 2964939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with an LHRH analogue in patients with advanced pancreatic cancer. A preliminary report.
    Andrén-Sandberg A
    Acta Chir Scand; 1990 Aug; 156(8):549-51. PubMed ID: 2146849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.
    Kaisary AV; Ryan PG; Turkes A; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1988; 260():89-100. PubMed ID: 2966408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of advanced cancer of the prostate using LHRH analogs. How can a possible initial flare-up be prevented?].
    Bouffioux C; Denis L; Mahler C; de Leval J
    Acta Urol Belg; 1986; 54(3):304-8. PubMed ID: 2946208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.